Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8698 |
High Similarity |
NPD8434 |
Phase 2 |
0.85 |
High Similarity |
NPD5760 |
Phase 2 |
0.85 |
High Similarity |
NPD5761 |
Phase 2 |
0.8293 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7874 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7449 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7391 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7363 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7293 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7293 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7184 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7168 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD920 |
Approved |
0.7159 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7143 |
Intermediate Similarity |
NPD919 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7111 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7049 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7041 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7236 |
Approved |
0.701 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6978 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.697 |
Remote Similarity |
NPD6100 |
Approved |
0.697 |
Remote Similarity |
NPD6099 |
Approved |
0.6966 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD2800 |
Approved |
0.694 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7054 |
Approved |
0.6923 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7239 |
Suspended |
0.6909 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6902 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6901 |
Remote Similarity |
NPD6273 |
Approved |
0.6893 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD7472 |
Approved |
0.6879 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6878 |
Remote Similarity |
NPD7907 |
Approved |
0.6872 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6868 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6863 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6863 |
Remote Similarity |
NPD4665 |
Approved |
0.6857 |
Remote Similarity |
NPD37 |
Approved |
0.6856 |
Remote Similarity |
NPD6780 |
Approved |
0.6856 |
Remote Similarity |
NPD6776 |
Approved |
0.6856 |
Remote Similarity |
NPD6782 |
Approved |
0.6856 |
Remote Similarity |
NPD6777 |
Approved |
0.6856 |
Remote Similarity |
NPD6778 |
Approved |
0.6856 |
Remote Similarity |
NPD6779 |
Approved |
0.6856 |
Remote Similarity |
NPD6781 |
Approved |
0.6852 |
Remote Similarity |
NPD3268 |
Approved |
0.6836 |
Remote Similarity |
NPD4965 |
Approved |
0.6836 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD4966 |
Approved |
0.6833 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6829 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6826 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD5763 |
Approved |
0.6826 |
Remote Similarity |
NPD5762 |
Approved |
0.6826 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD2801 |
Approved |
0.6811 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6807 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6805 |
Remote Similarity |
NPD3750 |
Approved |
0.68 |
Remote Similarity |
NPD7874 |
Approved |
0.68 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD3057 |
Approved |
0.6776 |
Remote Similarity |
NPD7228 |
Approved |
0.6766 |
Remote Similarity |
NPD2796 |
Approved |
0.676 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6751 |
Remote Similarity |
NPD7697 |
Approved |
0.6751 |
Remote Similarity |
NPD7698 |
Approved |
0.6751 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6748 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6746 |
Remote Similarity |
NPD1243 |
Approved |
0.6744 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6737 |
Remote Similarity |
NPD8360 |
Approved |
0.6737 |
Remote Similarity |
NPD8361 |
Approved |
0.6728 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6727 |
Remote Similarity |
NPD447 |
Suspended |
0.6726 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6726 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6726 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD2344 |
Approved |
0.6726 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6723 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6718 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6717 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6717 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6717 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6717 |
Remote Similarity |
NPD8319 |
Approved |
0.6708 |
Remote Similarity |
NPD5647 |
Approved |
0.6706 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD1512 |
Approved |
0.6703 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD3533 |
Approved |
0.6701 |
Remote Similarity |
NPD2972 |
Approved |
0.67 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6685 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6684 |
Remote Similarity |
NPD4107 |
Approved |
0.6683 |
Remote Similarity |
NPD7801 |
Approved |
0.6667 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2403 |
Approved |
0.6667 |
Remote Similarity |
NPD6190 |
Approved |
0.6649 |
Remote Similarity |
NPD8435 |
Approved |
0.6648 |
Remote Similarity |
NPD5711 |
Approved |
0.6648 |
Remote Similarity |
NPD5710 |
Approved |
0.6646 |
Remote Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6616 |
Remote Similarity |
NPD2491 |
Approved |
0.6615 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6607 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6607 |
Remote Similarity |
NPD3748 |
Approved |
0.6603 |
Remote Similarity |
NPD9092 |
Discovery |
0.6601 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6601 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6598 |
Remote Similarity |
NPD6534 |
Approved |
0.6598 |
Remote Similarity |
NPD6535 |
Approved |
0.6595 |
Remote Similarity |
NPD2163 |
Approved |
0.659 |
Remote Similarity |
NPD1511 |
Approved |
0.6588 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6587 |
Remote Similarity |
NPD6651 |
Approved |
0.6587 |
Remote Similarity |
NPD6653 |
Approved |
0.6585 |
Remote Similarity |
NPD7095 |
Approved |
0.6582 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6582 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6571 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.657 |
Remote Similarity |
NPD2309 |
Approved |
0.6566 |
Remote Similarity |
NPD4482 |
Phase 3 |
0.6562 |
Remote Similarity |
NPD1608 |
Approved |
0.6562 |
Remote Similarity |
NPD9717 |
Approved |
0.6559 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6557 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6556 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.6556 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.6548 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6545 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6545 |
Remote Similarity |
NPD3764 |
Approved |
0.6545 |
Remote Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.6545
|
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |